ArticleNanomaterials (Basel, Switzerland)2021
Solvothermal Synthesis Combined with Design of Experiments-Optimization Approach for Magnetite Nanocrystal Clusters.
Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Microfluidic Synthesis of Magnetite Nanoparticles for the Controlled Release of Antibiotics.Pharmaceutics · 2023Article
- Magnetite Microspheres for the Controlled Release of Rosmarinic Acid.Pharmaceutics · 2022Article
- Fabrication of Doxorubicin-Loaded Lipid-Based Nanocarriers by Microfluidic Rapid Mixing.Biomedicines · 2022Article
- Changes in the Cardiotoxic Effects of Lead Intoxication in Rats Induced by Muscular Exercise.International journal of molecular sciences · 2022Article
- Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives.Pharmaceutics · 2022Review
- Cardioinotropic Effects in Subchronic Intoxication of Rats with Lead and/or Cadmium Oxide Nanoparticles.International journal of molecular sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Magnetite nanocrystal clusters are being investigated for their potential applications in catalysis, magnetic separation, and drug delivery. Controlling their size and size distribution is of paramount importance and often requires tedious trial-and-error experimentation to determine the optimal conditions necessary to synthesize clusters with the desired properties. In this work, magnetite nanocrystal clusters were prepared via a one-pot solvothermal reaction, starting from an available protocol. In order to optimize the experimental factors controlling their synthesis, response surface methodology (RSM) was used. The size of nanocrystal clusters can be varied by changing the amount of stabilizer (tribasic sodium citrate) and the solvent ratio (diethylene glycol/ethylene glycol). Tuning the experimental conditions during the optimization process is often limited to changing one factor at a time, while the experimental design allows for variation of the factors' levels simultaneously. The efficiency of the design to achieve maximum refinement for the independent variables (stabilizer amount, diethylene glycol/ethylene glycol (DEG/EG) ratio) towards the best conditions for spherical magnetite nanocrystal clusters with desirable size (measured by scanning electron microscopy and dynamic light scattering) and narrow size distribution as responses were proven and tested. The optimization procedure based on the RSM was then used in reverse mode to determine the factors from the knowledge of the response to predict the optimal synthesis conditions required to obtain a good size and size distribution. The RSM model was validated using a plethora of statistical methods. The design can facilitate the optimization procedure by overcoming the trial-and-error process with a systematic model-guided approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.